RNAi Therapeutics Market Size, Value, and Competitive Overview:
[200 Pages Research Report] The global RNAi Therapeutics Market size was valued at USD YY billion in 2022, and the market is projected to reach USD YY billion by the end of 2023, with growth at a CAGR of 10.2% during the forecast report 2023-2030.
Market Segmentation:
By Application:
- Drug Discovery
- Development
By Therapeutics:
- Oncology
- Ocular Disorders
- Respiratory Disorders
- Hepatitis B And C
- Autoimmune Hepatitis
- Neurological Disorders
- Other Therapeutics
Regional Clasification:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Some of the Major Countries Covered in the Market:
The major companies included in the global RNAi therapeutics market are Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals (Novo Nordisk A/S), Thermofisher Scientific, Silence Therapeutics PLC.
